Trademark: 90708204
Status Date
Monday, July 17, 2023
Filing Date
Thursday, May 13, 2021
Published for Opposition
Tuesday, October 19, 2021
Abandoned Date
Monday, July 17, 2023
5 pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Jul 17, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 17, 2023
Abandonment - No Use Statement Filed
Dec 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2022
Teas Change Of Correspondence Received
Dec 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Teas Change Of Owner Address Received
Oct 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2022
Sou Extension 2 Granted
Oct 24, 2022
Sou Extension 2 Filed
Oct 24, 2022
Teas Extension Received
Mar 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2022
Sou Extension 1 Granted
Mar 25, 2022
Sou Extension 1 Filed
Mar 25, 2022
Teas Extension Received
Dec 14, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2021
Published For Opposition
Sep 29, 2021
Notification Of Notice Of Publication E-Mailed
Sep 14, 2021
Approved For Pub - Principal Register
Sep 8, 2021
Assigned To Examiner
Aug 12, 2021
New Application Office Supplied Data Entered
May 17, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
